Barclays Downgrades Revvity to Equal-Weight, Lowers Price Target to $95

Benzinga Newsdesk www.benzinga.com Negative 64.1%

Neg 64.1% Neu 0% Pos 0%

Barclays analyst Luke Sergott downgrades Revvity (NYSE:RVTY) from Overweight to Equal-Weight and lowers the price target from $118 to $95.